SPDR S&P Biotech ETF Rating $93.54 +0.96 (+1.04%) Closing price 04:10 PM EasternExtended Trading$93.62 +0.08 (+0.08%) As of 06:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.77Holdings in XBI have an aggregate rating of Moderate Buy based on 753 analyst ratings issued in the past year covering 50 companies (75.8% of the portfolio).XBI Aggregate Price Target$93.54-0.04% DownsideHigh Prediction$93.54Average Prediction$93.54Low Prediction$93.54Holdings in XBI have an aggregate price target of $93.54 and a range of $93.54 to $93.54 covering 50 companies (75.8% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy30 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.73%NBIXNeurocrine Biosciences$153.29+1.7%4.6473 of 5 stars2.82$165.40 7.9%22Upcoming EarningsInsider TradeAnalyst RevisionNews Coverage2.49%UTHRUnited Therapeutics$352.30-5.5%4.3175 of 5 stars2.73$378.36 7.4%15Insider TradeShort Interest ↓Positive News2.48%NTRANatera$176.27+4.8%2.5314 of 5 stars3.00$165.88 -5.9%17Analyst ForecastInsider Trade2.46%INCYIncyte$73.77+0.1%4.641 of 5 stars2.35$75.71 2.6%20Short Interest ↓2.45%ABBVAbbVie$175.54+0.2%4.9758 of 5 stars2.88$205.00 16.8%24Upcoming EarningsAnalyst ForecastShort Interest ↓Positive News2.44%GILDGilead Sciences$96.95+1.4%4.7661 of 5 stars2.70$98.39 1.5%27Analyst ForecastShort Interest ↑News CoveragePositive News2.43%AMGNAmgen$284.02+0.8%4.87 of 5 stars2.44$314.00 10.6%27Upcoming EarningsAnalyst ForecastPositive News2.41%ALNYAlnylam Pharmaceuticals$277.16+1.2%4.0564 of 5 stars2.72$298.61 7.7%25Insider TradeAnalyst RevisionNews Coverage2.41%INSMInsmed$76.29-2.2%2.7115 of 5 stars3.00$83.67 9.7%16Short Interest ↑2.37%PCVXVaxcyte$91.95+3.7%2.0599 of 5 stars3.00$145.71 58.5%8Positive News2.30%SRPTSarepta Therapeutics$114.45-0.9%4.9345 of 5 stars2.91$178.71 56.2%22Analyst ForecastAnalyst Revision2.29%BMRNBioMarin Pharmaceutical$63.88+0.7%4.9725 of 5 stars2.74$94.20 47.5%23Short Interest ↓2.21%BIIBBiogen$146.23+1.3%4.7677 of 5 stars2.43$228.80 56.5%28Analyst ForecastAnalyst Revision2.21%REGNRegeneron Pharmaceuticals$683.08-0.6%4.7274 of 5 stars2.65$1,004.57 47.1%23Analyst ForecastAnalyst Revision2.20%HALOHalozyme Therapeutics$56.42+1.1%4.5369 of 5 stars2.60$60.89 7.9%10Short Interest ↑Positive News2.19%VRTXVertex Pharmaceuticals$438.40-0.7%4.2226 of 5 stars2.53$494.76 12.9%30Analyst ForecastAnalyst RevisionNews Coverage1.97%EXASExact Sciences$56.03+2.1%4.8108 of 5 stars2.95$72.76 29.9%191.94%MRNAModerna$41.04+0.8%4.5792 of 5 stars2.09$67.26 63.9%23Analyst Forecast1.77%TGTXTG Therapeutics$33.360.0%3.9017 of 5 stars2.83$40.67 21.9%61.69%BPMCBlueprint Medicines$114.05-0.2%1.0522 of 5 stars2.65$123.56 8.3%20Analyst ForecastShort Interest ↑1.66%MDGLMadrigal Pharmaceuticals$338.29+3.7%4.1648 of 5 stars2.69$351.67 4.0%13Insider TradeShort Interest ↓Gap Up1.62%VKTXViking Therapeutics$33.69+0.8%4.0413 of 5 stars3.15$106.75 216.9%13Upcoming Earnings1.57%BBIOBridgeBio Pharma$35.97-1.3%4.0959 of 5 stars2.86$48.08 33.7%14Short Interest ↑1.56%ADMAADMA Biologics$16.10-1.7%4.0617 of 5 stars3.25$21.25 32.0%4Short Interest ↑1.42%CYTKCytokinetics$49.97+2.7%4.137 of 5 stars2.87$82.79 65.7%151.42%EXELExelixis$32.93-0.1%4.5568 of 5 stars2.53$36.06 9.5%19Upcoming EarningsAnalyst Forecast1.42%ROIVRoivant Sciences$11.37+2.2%3.1466 of 5 stars2.88$17.93 57.7%81.41%IONSIonis Pharmaceuticals$33.32+1.3%4.596 of 5 stars2.68$60.65 82.0%191.32%APLSApellis Pharmaceuticals$30.39+3.1%4.7225 of 5 stars2.63$46.71 53.7%19Analyst ForecastShort Interest ↓Analyst Revision1.26%RVMDRevolution Medicines$43.07+5.3%4.3787 of 5 stars3.08$66.25 53.8%121.23%CRSPCRISPR Therapeutics$42.04+2.0%2.6818 of 5 stars2.47$78.38 86.4%19Short Interest ↑1.14%ALKSAlkermes$31.91+1.1%3.8743 of 5 stars2.64$36.00 12.8%11Short Interest ↓Analyst RevisionNews Coverage1.04%SMMTSummit Therapeutics$22.36+3.3%2.9116 of 5 stars2.86$33.57 50.1%70.92%RNAAvidity Biosciences$32.63+2.2%1.4665 of 5 stars3.00$65.80 101.7%100.89%BHVNBiohaven$38.94+3.2%2.6867 of 5 stars3.07$63.00 61.8%14Short Interest ↑0.87%ACLXArcellx$67.53+4.6%2.9852 of 5 stars3.13$105.93 56.9%15Short Interest ↑0.83%NUVLNuvalent$87.75+2.6%2.4115 of 5 stars2.86$112.36 28.0%14Insider TradeNews CoveragePositive News0.80%SWTXSpringWorks Therapeutics$37.23+1.9%1.8043 of 5 stars3.00$70.00 88.0%6Positive News0.79%TWSTTwist Bioscience$51.14+3.3%2.5942 of 5 stars2.70$51.90 1.5%10Upcoming EarningsInsider TradeNews Coverage0.76%RAREUltragenyx Pharmaceutical$43.40+2.2%4.7394 of 5 stars2.93$92.43 113.0%14Analyst RevisionPositive News0.72%KRYSKrystal Biotech$156.07-0.1%4.8532 of 5 stars3.00$206.67 32.4%8Short Interest ↓0.70%RXRXRecursion Pharmaceuticals$7.69+7.4%2.2439 of 5 stars2.50$8.75 13.8%4Gap Up0.68%VCYTVeracyte$46.14+3.8%3.9536 of 5 stars2.67$42.00 -9.0%9Analyst DowngradeNews Coverage0.64%PTGXProtagonist Therapeutics$39.12+2.4%3.2487 of 5 stars3.00$53.78 37.5%9Positive News0.64%CLDXCelldex Therapeutics$25.26-1.0%1.9906 of 5 stars2.88$62.25 146.4%8Analyst ForecastShort Interest ↑0.64%GERNGeron$2.88-0.3%3.6584 of 5 stars3.09$7.25 151.7%11Positive News0.63%SRRKScholar Rock$40.40-5.1%3.2974 of 5 stars3.14$40.43 0.1%7Analyst ForecastNews Coverage0.62%PTCTPTC Therapeutics$46.15+2.1%4.0918 of 5 stars2.47$55.00 19.2%150.60%TVTXTravere Therapeutics$21.05+2.9%2.1461 of 5 stars2.92$24.00 14.0%13Analyst Revision0.59%IOVAIovance Biotherapeutics$6.21+2.3%4.2818 of 5 stars2.88$23.00 270.4%8News Coverage This page (NYSEARCA:XBI) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrillion-Dollar Crypto PlayPotential $20-trillion opportunity? Put $500 into THIS AI Coin for 2025… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
